The objective of this study was to investigate the molecular signaling via Her2, IL33, EGFR, and MUC1 expressions after given Rhodomyrtus tomentosa as a botanical treatment for cancer to the breast via organs and the bloods. The gene discussed is IL33; the disease is cancer.